3 Indian drugmakers sign agreement with Gilead Sciences, US to produce and sell Remdesivir

indica News Bureau- Gilead Sciences, the US drug maker has signed a non-exclusive voluntary licensing agreements with three Indian pharmaceutical companies — Hyderabad-based Hetero Labs, Mumbai-headquartered Cipla, and Noida-based Jubilant Life Sciences to manufacture and sell the anti-viral drug to people who have severe COVID-19 infection. US-based Mylan which has a strong base in India […]

Gilead’s Remdesivir receives emergency use authorization (EUA) from US Food and Drug Administration

indica News Bureau- Gilead Sciences Inc.’s antiviral drug remdesivir was cleared by U.S. regulators for emergency use in Covid-19 patients, becoming the first medication backed by early clinical data to be made available to fight the novel coronavirus. Remdesivir reduced the time it took hospitalized Covid-19 patients to recover in an interim analysis of an […]